Salute Pubblica
- New England Journal of Medicine , 16 marzo 2022 | “Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron”
- New England Journal of Medicine, 2 febbraio 2022| “Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant”
- ECDC , 31 gennaio 2022 | “Overview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA”
- ECDC , 28 gennaio 2022 | “Guidance on ending the isolation period for people with COVID-19, third update”
- JAMA , 24 gennaio 2022 | “Preventing SARS-CoV-2 Transmission in Health Care Settings in the Context of the Omicron Variant”
- JAMA, editoriale 24 gennaio 2022 | “Defining Optimal Respiratory Support for Patients With COVID-19”
- JAMA, 21 gennaio 2022 | “Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants”
- JAMA, 21 gennaio 2022 editoriale | “Booster Vaccination to Prevent COVID-19 in the Era of OmicronAn Effective Part of a Layered Public Health Approach”
- New England Journal of Medicine, 20 gennaio 2022 | “Rapid Diagnostic Testing for SARS-CoV-2”
- New England Journal of Medicine , 12 gennaio 2022 | “Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines”
- Nature, 12 gennaio 2022 | “COVID vaccines safely protect pregnant people: the data are in”
- Nature, 5 gennaio 2022 | “Omicron’s feeble attack on the lungs could make it less dangerous
- Science, 4 gennaio 2022 | “Omicron cases are exploding. Scientists still don’t know how bad the wave will be”
- New England Journal of Medicine, 29 dicembre 2021 | “Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection”
- New England Journal of Medicine , 23 dicembre 2021 | “BNT162b2 Vaccine Booster and Mortality Due to Covid-19”
- New England Journal of Medicine , 23 dicembre editoriale | ” Booster Doses and Prioritizing Lives Saved”
- New England Journal of Medicine, 23 dicembre 2021 | “Protection against Covid-19 by BNT162b2 Booster across Age Groups”
- Eurosurveillance, 9 dicembre 2021 | “Increasing risk of breakthrough COVID-19 in outbreaks with high attack rates in European long-term care facilities, July to October 2021 “
- The Lancet Respiratory Medicine, 1 dicembre 2021 | “Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial”
- ECDC, 2 dicembre 2021 | “Implications of the further emergence and spread of the SARS-CoV-2 B.1.1.529 variant of concern (Omicron) for the EU/EEA – first update”
- New England Journal of Medicine, 25 novembre 2021 | “Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents”
- Nature, 24 novembre 2021 | ”Diagnostic performance of rapid antigen tests (RATs) for SARS-CoV-2 and their efficacy in monitoring the infectiousness of COVID-19 patients”
- The Lancet Microbe, 15 novembre 2021 | “Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis”
- New England Journal of Medicine , 11 novembre 2021 | “The Future of SARS-CoV-2 Vaccination — Lessons from Influenza”
- The Lancet, 11 novembre 2021 | “Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial”
- MMWR, 5 novembre 2021 | “The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021”
- JAMA, 4 novembre 2021 | “Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity”
- JAMA, editoriale 4 novembre 2021 | “Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity”
- JAMA, 4 novembre 2021 | “Understanding Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination”
- The Lancet, 29 ottobre 2021 | “Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study”
- MMWR, 29 ottobre 2021 | “The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021”
- European Center for Disease Control (ECDC), 26 ottobre 2021 | “Options for the use of rapid antigen detection tests for COVID-19 in the EU/EEA – first update”
- New England Journal of Medicine, 15 ottobre 2021 | “Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines”
- New England Journal of Medicine, 7 ottobre 2021 | “Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel”
- ECDC, 30 settembre 2021 | “Assessing SARS-CoV-2 circulation, variants of concern, non-pharmaceutical interventions and vaccine rollout in the EU/EEA, 16th update”
- New England Journal of Medicine, 22 settembre 2021 | “Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase”
- New England Journal of Medicine, 15 settembre 2021 | “Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel”
- Nature, 14 settembre 2021 | “Contact tracing is an imperfect tool for controlling COVID-19 transmission and relies on population adherence”
- New England Journal of Medicine , 8 settembre 2021 | “Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings”
- New England Journal of Medicine , editoriale 8 settembre 2021 | “Covid-19 Vaccine Effectiveness and the Test-Negative Design”
- JAMA, 3 settembre 2021 | “Surveillance for Adverse Events After COVID-19 mRNA Vaccination”
- JAMA, editoriale 3 settembre 2021 | “Safety Surveillance of COVID-19 mRNA Vaccines Through the Vaccine Safety Datalink”
- JAMA, 25 agosto 2021 | “Influenza’s Unprecedented Low Profile During COVID-19 Pandemic Leaves Experts Wondering What This Flu Season Has in Store”
- New England Journal of Medicine, 18 agosto 2021 | “Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors”
- MMWR, 18 agosto 2021 | “Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021”
- MMWR, 18 agosto 2021 | “Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021”
- MMWR, 30 luglio 2021 | “Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage”
- New England Journal of Medicicne, 21 luglio 2021 | “Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant”
- MMWR, 9 luglio 2021 | “Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021”
- New England Journal of Medicine, 8 luglio 2021 | “SARS-CoV-2 Variants and Vaccines”
- New England Journal of Medicine, 7 luglio 2021 | “Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile”
- New England Journal of Medicine , 23 giugno 2021| “SARS-CoV-2 Variants and Vaccines”
- MMWR, 8 giugno 2021 | “Decreases in COVID-19 Cases, Emergency Department Visits, Hospital Admissions, and Deaths Among Older Adults Following the Introduction of COVID-19 Vaccine — United States, September 6, 2020–May 1, 2021”
- Istituto Superiore Sanità. 3 giugno 2021 | “Impatto della vaccinazione COVID-19 sul rischio di infezione da SARS-CoV-2 e successivo ricovero e decesso in Italia (27.12.2020-30.05.2021)”
- Science, 20 maggio 2021 | “Face masks effectively limit the probability of SARS-CoV-2 transmission”
- New England Journal of Medicine, 19 maggio 2021 | “Contact Tracing for Covid-19 — A Digital Inoculation against Future Pandemics”
- MMWR, 14 maggio 2021 | “The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021”
- Istituto Superiore di Sanità, 11 maggio 2021 | “Impatto della vaccinazione COVID-19 sul rischio di infezione da SARS-CoV-2 e successivo ricovero e decesso in Italia (27.12.2020-03.05.2021)”
- ECDC, 6 maggio 2021 | “Considerations on the use of rapid antigen detection (including self-) tests for SARS-CoV-2 in occupational settings”
- BMJ, 5 maggio 2021 | “Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study”
- MMWR, 21 aprile 2021 | “COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program — Kentucky, March 2021”
- New England Journal of Medicine, 21 aprile 2021 | “Vaccine Breakthrough Infections with SARS-CoV-2 Variants”
- MMWR, 21 aprile 2021 | “Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members — Chicago, Illinois, December 2020–March 2021”
- New England Journal of Medicine, 14 aprile 2021 | “SARS-CoV-2 Antibody Response in Persons with Past Natural Infection”
- The Lancet, 9 aprile 2021 | “SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)”
- The Lancet, editoriale 9 aprile 2021 | “Correlates of protection from SARS-CoV-2 infection”
- ECDC, 29 marzo 2021 | “Risk of SARS-CoV-2 transmission from newly-infected individuals with documented previous infection or vaccination”
- Nature Medicine, 29 marzo 2021 | “Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine”
- MMWR, 29 marzo 2021 | “Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021”
- New England Journal of Medicine, 24 marzo 2021 | “New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications”
- New England Journal of Medicine, 23 marzo 2021 | “BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers”
- New England Journal of Medicine, 23 marzo 2021 | “SARS-CoV-2 Infection after Vaccination in Health Care Workers in California”
- Science, 19 marzo 2021 | “SARS-CoV-2 transmission without symptoms”
- JAMA, 10 marzo 2021 | “CDC Interim Recommendations for Fully Vaccinated PeopleAn Important First Step”
- JAMA, 3 marzo 2021 | “The Potential Future of the COVID-19 PandemicWill SARS-CoV-2 Become a Recurrent Seasonal Infection?”
- JAMA, 4 marzo 2021 | “Approaches for Optimal Use of Different COVID-19 VaccinesIssues of Viral Variants and Vaccine Efficacy”
- ECDC , 3 marzo 2021 | “Methods for the detection and identification of SARS-CoV-2 variants”
- The Lancet, 19 febbraio 2021 | “Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials”
- New England Journal of Medicine, 18 febbraio 2021 | “Vaccinating Children against Covid-19 — The Lessons of Measles”
- Nature, 15 febbraio 2021 | “Diagnostics for SARS-CoV-2 infections”
- ECDC, 15 febbraio 2021 | “SARS-CoV-2increased circulation of variants of concern and vaccine rollout in the EU/EEA,14thupdate”
- The Lancet Health Policy, 12 febbraio 2021 | “Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment”
- Center for Disease Control and Prevention, 10 febbraio 2021 | “Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS-CoV-2 Transmission and Exposure, 2021”
- The Lancet, 2 febbraio 2021 | “Understanding the drivers of transmission of SARS-CoV-2”
- European Centre for Disease Prevention and Control, 1 febbraio 2021 | “Overview of the implementation of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA”
- The Lancet Global Health, 28 gennaio 2021 | “SARS-CoV-2 testing for public health use: core principles and considerations for defined use settings”
- MMWR, 12 gennaio 2021 | “Mitigation Policies and COVID-19–Associated Mortality — 37 European Countries, January 23–June 30, 2020”
- European Centre for Disease Prevention and Control, 29 dicembre 2020 | “Risk related tospread of new SARS-CoV-2 variants of concern the EU/EEA”
- Annals of Internal Medicine , 8 dicembre 2020 | “Dynamics and Correlation Among Viral Positivity, Seroconversion, and Disease Severity in COVID-19”
- European Centre for Disease Prevention and Control, 2 dicembre 2020 | “Overview of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA and the UK”
- The Lancet Microbe , 19 novembre 2020 | “SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis”
- JAMA, 13 novembre 2020 | “The Need for More and Better Testing for COVID-19”
- JAMA Internal Medicine , 12 novembre 2020 | “Assessment of SARS-CoV-2 RNA Test Results Among Patients Who Recovered From COVID-19 With Prior Negative Results” Editor’s note: “Challenges in Testing for SARS-CoV-2 Among Patients Who Recovered From COVID-19
- JAMA Internal Medicine, 30 ottobre 2020 | “COVID-19 Test Result Turnaround Time for Residents and Staff in US Nursing Homes”
- The Lancet Infectious Diseases, 22 ottobre 2020 | “The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries
- JAMA, 19 ottobre 2020 | “ Herd Immunity and implications for SARS-CoV-2 control “
- New England Journal of Medicine, 30 settembre 2020 | “Rethinking Covid-19 Test Sensitivity — A Strategy for Containment”
- The Lancet Respiratory Medicine, 29 settembre 2020 | “False-positive COVID-19 results: hidden problems and costs”
- The Lancet, 24 settembre 2020 | “Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe
- European Centre for Disease Prevention and Control (ECDC), 21 settembre 2020 | “Reinfection with SARS-Cov-2 : consideration for public health response”
- European Centre for Disease Prevention and Control (ECDC) , 18 settembre 2020 | “COVID-19 testing strategies and objectives”
- JAMA Otolaringology, 17 settembre 2020 | “SARS-CoV-2 Nasopharyngeal Swab Testing—False-Negative Results From a Pervasive Anatomical Misconception”
- New England Journal of Medicine, 28 agosto 2020 | “Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2
- Clinical Infectious Diseases, 25 agosto 2020 | “Duration of SARS-CoV-2 Infectivity: When is it Safe to Discontinue Isolation?”
- BMJ, 25 agosto 2020 | “Two metres or one: what is the evidence for physical distancing in covid-19?”
- New England Journal of Medicine | “Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2”
- JAMA,20 agosto 2020 | “Flu Vaccination Urged During COVID-19 Pandemic”
- JAMA Internal Medicine, 11 agosto 2020 | “Filtration Efficiency of Hospital Face Mask Alternatives Available for Use During the COVID-19 Pandemic”
- Ministero della Salute, 3 agosto 2020 | “Primi risultati dell’indagine di sieroprevalenza SARS-CoV-2″
- The Lancet, Child & Adolescent Health, 3 agosto 2020 | “Determining the optimal strategy for reopening schools, the impact of test and trace interventions, and the risk of occurrence of a second COVID-19 epidemic wave in the UK: a modelling study”
- The Lancet, 31 luglio 2020 | “Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study”
- BMJ Journals-Thorax, 24 luglio 2020 | “Face coverings and mask to minimise droplet dispersion and aerosolisation: a video case study”
- Istituto Mario Negri, 23 luglio 2020 | “Ragazzi in quarantena: quali conseguenze nella quotidianità?”
- The Lancet Public Health, 16 luglio 2020 | “Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study”
- JAMA, 13 luglio 2020 | “Airborne Transmission of SARS-CoV-2. Theoretical Considerations and Available Evidence”
- Istituto Mario Negri, 10 luglio 2020 | “Didattica a distanza a causa del Covid-19: strumento adatto a tutti?”
- The Lancet Infectious Diseases, 1 luglio 2020 | “Association between mobility patterns and COVID-19 transmission in the USA: a mathematical modeling study”
- New England Journal of Medicine, 18 giugno 2020 | ”Challenges of “Return to Work” in an Ongoing Pandemic”
- New England Journal of Medicine, 5 giugno 2020 | “False Negative Tests for SARS-CoV-2 Infection – Challenges and Implications”
- New England Journal of Medicine, 5 giugno 2020 | “Waiting for Certainty on Covid-19 Antibody Tests — At What Cost?”
- BMJ, 3 giugno 2020 | “Should governments continue lockdown to slow the spread of covid-19?”
- The Lancet Public Health, 2 giugno 2020 | “Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study”
- The Lancet, 2 giugno 2020 | “Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis”
- quotidianosanità.it, 3 giugno 2020 | “Covid. Idrossiclorochina. Oms riavvia sperimentazione: “Non ci sono evidenze su dati mortalità che giustifichino modifiche al protocollo originale del trial”
- Travel Medicine and Infectious Disease, 28 maggio 2020 | “Efficacy of face mask in preventing respiratory virus transmission: A systematic review and meta-analysis”
- PNAS (Proceedings of the National Academy of Sciences), 13 maggio 2020 | ”The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission”
- Nature, 19 maggio 2020 | “Coronavirus contact-tracing apps: can they slow the spread of COVID-19?”
- Istituto Superiore di Sanità, versione 14 maggio 2020 | “Indicazioni ad interim per la sanificazione degli ambienti interni nel contesto sanitario e assistenziale per prevenire la trasmissione di SARS-CoV 2”
- Nature, 6 maggio 2020 | Editoriale – Coronavirus: share lessons on lifting lockdowns
- Nature, 29 aprile 2020 | ”Show evidence that apps for COVID-19 contact-tracing are secure and effective”
- Istituto Mario Negri, 29 aprile 2020 | “Covid-19 : le acque reflue sono indicatori di diffusione”
- New England Journal of Medicine, 28 aprile 2020 | ”Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy”
- The Lancet, 27 aprile 2020 | ”What policy makers need to know about COVID-19 protective immunity”
- Nature, 17 aprile 2020 | “ Will antibody test for the coronavirus really change everything?”
- The Lancet, 17 aprile 2020| ” COVID-19: the case for health-care worker screening to prevent hospital transmission”
- Istituto Mario Negri, 17 aprile 2020 | “Covid-19: come prevenire una seconda ondata epidemica”
- JAMA, 10 aprile | “Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China”
- ALTEMPS – Alta Scuola di Economia e Management dei Sistemi Sanitari, 15 aprile | Analisi dei modelli organizzativi di risposta al Covid-19
- La Civiltà Cattolica, 4 aprile 2020 | Per ripartire dopo l’emergenza COVID – 19
- The Lancet, 13 marzo 2020 | COVID-19 and Italy: what next?